Poirot Catherine, Schubert Benoît
Groupe hospitalier Pitié-Salpêtrière, unité fonctionnelle de biologie de la reproduction, 83, boulevard de l'Hôpital, 75013 Paris, France.
Bull Cancer. 2011 May;98(5):489-99. doi: 10.1684/bdc.2011.1362.
Gonadotoxic therapies during childhood may impair future fertility in adult life and fertility preservation techniques should be discussed before starting gonadotoxic therapies. In both sexes, fertility preservation often means immature gametes cryopreservation. For girls, ovarian tissue cryopreservation is the only existing option to preserve fertility in prepubertal girls at risk of premature ovarian failure. This promising approach involves the storage of a large number of follicles, which could subsequently be transplanted or cultured to obtain mature oocytes. The results of ovarian tissue cryopreservation in adults are encouraging. At least nine children have been born after orthotopic reimplantation of frozen-thawed ovarian cortex. None of these pregnancies were obtained by reimplantation of ovarian tissue harvested before puberty; however, the probability of restoring fertility should be higher for younger girls, as their ovarian cortex clearly contains a large number of follicules. In vitro growth of primordial follicles to mature oocytes could be an option but this goal has not yet reached in humans. This option may be reach in the future, when young patients are in their twenties or thirties. For boys, spermatogonial stem cells can be cryopreserved and uni or bilateral testicular pieces can be stored for future use. Animal data reveals that healthy offspring were reported after grafting of frozen testicular cell suspensions or tissue pieces in different species. Although recent data show promising results, restoring fertility by using frozen testicular cells after transplantation or in vitro culture is not shown yet. Then, immature testicular tissue cryopreservation for prepubertal boys is still an experimental procedure. However, as their use for restoring fertility should not be requested before 10-30 years, a long time is given for advances in medical research.
儿童期的性腺毒性疗法可能会损害成年后的生育能力,因此在开始性腺毒性疗法之前应讨论生育力保存技术。对于男性和女性而言,生育力保存通常意味着冷冻未成熟配子。对于女孩来说,卵巢组织冷冻保存是对有卵巢早衰风险的青春期前女孩保存生育力的唯一现有选择。这种有前景的方法涉及储存大量卵泡,随后可将其移植或培养以获得成熟卵母细胞。成人卵巢组织冷冻保存的结果令人鼓舞。至少有9名儿童在冻融卵巢皮质原位再植后出生。这些妊娠均不是通过移植青春期前采集的卵巢组织获得的;然而,年轻女孩恢复生育力的可能性应该更高,因为她们的卵巢皮质显然含有大量卵泡。原始卵泡体外生长为成熟卵母细胞可能是一种选择,但这一目标在人类中尚未实现。当年轻患者二三十岁时,这一选择可能在未来实现。对于男孩,精原干细胞可以冷冻保存,单侧或双侧睾丸组织块可以储存以备将来使用。动物数据显示,在不同物种中移植冷冻的睾丸细胞悬液或组织块后报告了健康后代。尽管最近的数据显示出有前景的结果,但移植或体外培养后使用冷冻睾丸细胞恢复生育力尚未得到证实。因此,青春期前男孩的未成熟睾丸组织冷冻保存仍然是一种实验性程序。然而,由于在10至30年内不应要求使用它们来恢复生育力,因此为医学研究的进展留出了很长时间。